GNRH1 and neoplasm: The cytotoxic LHRH analogs AN-152 and AN-207 are less toxic and much more effective in vivo than their respective radicals in inhibiting tumor growth in LHRH-receptor-positive models of human ovarian, mammary, endometrial, and prostatic cancers xenografted into nude mice [9,15,27,28].